The latest price target for Tenet Healthcare (NYSE:THC) was reported by Raymond James on November 22, 2024. The analyst firm set a price target for $195.00 expecting THC to rise to within 12 months (a possible 35.77% upside). 50 analyst firms have reported ratings in the last year.

The latest analyst rating for Tenet Healthcare (NYSE:THC) was provided by Raymond James, and Tenet Healthcare downgraded their outperform rating.

The last upgrade for Tenet Healthcare Corp happened on March 27, 2024 when Wolfe Research raised their price target to $122. Wolfe Research previously had a peer perform for Tenet Healthcare Corp.

The last downgrade for Tenet Healthcare Corp happened on November 22, 2024 when Raymond James changed their price target from $195 to $195 for Tenet Healthcare Corp.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Tenet Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Tenet Healthcare was filed on November 22, 2024 so you should expect the next rating to be made available sometime around November 22, 2025.

While ratings are subjective and will change, the latest Tenet Healthcare (THC) rating was a downgraded with a price target of $195.00 to $195.00. The current price Tenet Healthcare (THC) is trading at is $143.63, which is out of the analyst’s predicted range.